Kowa, Lilly Say Pitavastatin Cholesterol Drug Superior To Pravastatin
This article was originally published in PharmAsia News
Executive Summary
Kowa Pharmaceuticals America and Eli Lilly said a study has shown their jointly developed Livalo (pitavastatin) cholesterol drug to be superior in a comparison trial with pravastatin on certain patients.